Dosidal · Switzerland

Sandimmun Neoral, Kapseln

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:52656 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 52656
atc: L04AD01
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 1994-05-16
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: L04AD01
authorisation_number: 52656
form: KAPWE
holder: Novartis Pharma Schweiz AG
holder_partner_nr: 1006575
it_number: 07.15.0.
name: Sandimmun Neoral, Kapseln
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
wG7qfopojuXU77lXbHQrsAfgXGQgXN6ZKU8ooIfULsxX2FA5oHtW8a2C-gTo2kljk5Wuh_s4TimdZutuNZycTg
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:52656 · Related records in other markets · Dosidal